ES2095931T3 - Elementos de respuesta al acido retinoico beta, composiciones y pruebas. - Google Patents

Elementos de respuesta al acido retinoico beta, composiciones y pruebas.

Info

Publication number
ES2095931T3
ES2095931T3 ES91901044T ES91901044T ES2095931T3 ES 2095931 T3 ES2095931 T3 ES 2095931T3 ES 91901044 T ES91901044 T ES 91901044T ES 91901044 T ES91901044 T ES 91901044T ES 2095931 T3 ES2095931 T3 ES 2095931T3
Authority
ES
Spain
Prior art keywords
beta
response
elements
rethinoic
tests
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91901044T
Other languages
English (en)
Inventor
Henry Michael Sucov
Ronald Mark Evans
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Salk Institute for Biological Studies
Original Assignee
Salk Institute for Biological Studies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salk Institute for Biological Studies filed Critical Salk Institute for Biological Studies
Application granted granted Critical
Publication of ES2095931T3 publication Critical patent/ES2095931T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Paints Or Removers (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)

Abstract

LA PRESENTE INVENCION PROPORCIONA REGIONES DE CONTROL TRANSCRIPCIONALES, VECTORES DE EXPRESION QUE COMPRENDEN DICHAS REGIONES, CELULAS DE MAMIFEROS TRANSFORMADAS PARA TRANSCRIBIR Y EXPRESAR GENES DESDE DICHOS VECTORES, Y VARIOS METODOS DE ENSAYAR COMPUESTOS RESPECTO A LA ACTIVIDAD AGONISTA O ANTAGONISTA DE LAS HORMONAS, TODOS BASADOS EN EL DESCUBRIMIENTO DE ELEMENTOS DE RESPUESTA DEL RECEPTOR DE ACIDO (BETA)-RETINOICO, Y EN LA ACTIVACION DE DICHOS ELEMENTOS DE RESPUESTA EN TODAS LAS CELULAS DE MAMIFEROS SIN NECESIDAD DE TRANSFORMAR LAS CELULAS PARA EXPRESAR EL RECEPTOR INDEPENDIENTEMENTE DE SU EXPRESION ENDOGENA.
ES91901044T 1989-11-16 1990-11-13 Elementos de respuesta al acido retinoico beta, composiciones y pruebas. Expired - Lifetime ES2095931T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/438,757 US5091518A (en) 1989-11-16 1989-11-16 Beta retinoic acid response elements compositions and assays

Publications (1)

Publication Number Publication Date
ES2095931T3 true ES2095931T3 (es) 1997-03-01

Family

ID=23741886

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91901044T Expired - Lifetime ES2095931T3 (es) 1989-11-16 1990-11-13 Elementos de respuesta al acido retinoico beta, composiciones y pruebas.

Country Status (11)

Country Link
US (1) US5091518A (es)
EP (1) EP0502979B1 (es)
JP (1) JPH05504474A (es)
AT (1) ATE148166T1 (es)
AU (1) AU637871B2 (es)
CA (1) CA2072644A1 (es)
DE (1) DE69029812T2 (es)
DK (1) DK0502979T3 (es)
ES (1) ES2095931T3 (es)
GR (1) GR3022358T3 (es)
WO (1) WO1991007488A1 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260432A (en) * 1989-06-22 1993-11-09 Sloan-Kettering Institute For Cancer Research Human gamma retinoic acid receptor DNA
US5091518A (en) * 1989-11-16 1992-02-25 The Salk Institute For Biological Studies Beta retinoic acid response elements compositions and assays
US6492137B1 (en) * 1989-11-16 2002-12-10 The Salk Institute For Biological Studies Response element compositions and assays employing same
US5861274A (en) * 1990-03-22 1999-01-19 The Salk Institute For Biological Studies Nucleic acids encoding peroxisome proliferator-activated receptor
US5369028A (en) * 1990-04-03 1994-11-29 The Salk Institute Biotechnology/Industrial Associates, Inc. DNA and mRNA encoding human neuronal nicotinic acetylcholine receptor compositions and cells transformed with same
US6440681B1 (en) 1990-04-03 2002-08-27 Merck & Co., Inc. Methods for identifying agonists and antagonists for human neuronal nicotinic acetylcholine receptors
US5401629A (en) * 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
WO1992006715A1 (en) * 1990-10-12 1992-04-30 Seragen, Inc. Mammalian model of a malignant disorder
US5604115A (en) * 1990-12-21 1997-02-18 The Rockefeller University Liver enriched transcription factor
JPH06508507A (ja) * 1991-03-18 1994-09-29 ザ　ソールク　インスチチュート　フォア　バイオロジカル　スタディズ 受容体認識配列組成物およびこれを用いた分析法
SE500453C2 (sv) * 1991-10-07 1994-06-27 Karobio Ab Ett in vitro förfarande för utvärdering av en substans effekter
EP0552612A3 (en) * 1992-01-22 1993-10-20 Hoffmann La Roche Methods for determining and isolating compounds which bind directly to nucleosolic proteins
US6989242B1 (en) 1992-02-26 2006-01-24 The General Hospital Coporation Car receptors and related molecules and methods
US5756448A (en) * 1992-02-26 1998-05-26 The General Hospital Corporation Constitute activator of retinoid (CAR) receptor polypeptides
EP0688361B1 (en) * 1993-03-08 2004-10-13 Merck & Co., Inc. Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
GB2287941B (en) * 1993-11-08 1998-01-28 Salk Inst Biotech Ind Human alpha2 neuronal nicotinic acetylcholine receptor compositions and methods employing same
EP0769052A2 (en) * 1994-07-01 1997-04-23 The Salk Institute For Biological Studies Mammalian peroxisome proliferator-activated receptors and uses thereof
US5702914A (en) * 1994-12-21 1997-12-30 The Salk Institute For Biological Studies Use of reporter genes for retinoid receptor screening assays having novel retinoid-associated response elements
FR2732035B1 (fr) * 1995-03-23 1997-05-30 Agronomique Inst Nat Rech Procede de regulation de l'expression d'un gene dans un baculovirus, par un site de fixation d'un recepteur de l'acide retinoique, et vecteur pour la mise en oeuvre du dit procede
US6485967B1 (en) 1995-06-07 2002-11-26 Merck & Co., Inc. Human neuronal nicotinic acetylcholine receptor α6 and β3 nucleic acid
FR2735371B1 (fr) * 1995-06-19 1997-07-18 Cird Galderma Procede pour identifier des composes antagonistes des recepteurs rars
US6489441B1 (en) 1995-09-01 2002-12-03 The Salk Institute For Biological Studies Transcriptional co-repressor that interacts with nuclear hormone receptors
WO1997034144A1 (de) * 1996-03-14 1997-09-18 Schering Aktiengesellschaft Verfahren zum nachweis der wirkung von testsubstanzen unter verwendung von hühner-urokinase
EP0977892A1 (en) 1997-04-24 2000-02-09 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methods and compositions for use in modulating expression of matrix metalloproteinase genes
US6387673B1 (en) 1997-05-01 2002-05-14 The Salk Institute For Biological Studies Compounds useful for the modulation of processes mediated by nuclear hormone receptors, methods for the identification and use of such compounds
AU1395999A (en) * 1997-11-10 1999-05-31 Salk Institute For Biological Studies, The Methods for the use of inhibitors of co-repressors for the treatment of neoplastic diseases
CN106480024B (zh) * 2015-08-30 2020-10-20 南通大学附属医院 受维甲酸调控的具有浓度依赖效应的重组启动子及其使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0318500A4 (en) * 1986-08-01 1989-12-22 Genetics Inst INDUCIBLE HIGH MIRROR EXPRESSION FOR HETEROLOGICAL GENES.
US5091518A (en) * 1989-11-16 1992-02-25 The Salk Institute For Biological Studies Beta retinoic acid response elements compositions and assays
EP0999271A3 (en) * 1990-02-09 2003-04-02 The Salk Institute For Biological Studies Retinoid receptor compositions and methods
AU655417B2 (en) * 1990-03-22 1994-12-22 Salk Institute For Biological Studies, The Insect retinoid receptor compositions and methods

Also Published As

Publication number Publication date
DE69029812T2 (de) 1997-06-05
EP0502979A4 (en) 1993-02-10
US5091518A (en) 1992-02-25
WO1991007488A1 (en) 1991-05-30
EP0502979A1 (en) 1992-09-16
DE69029812D1 (de) 1997-03-06
DK0502979T3 (da) 1997-04-07
GR3022358T3 (en) 1997-04-30
AU637871B2 (en) 1993-06-10
EP0502979B1 (en) 1997-01-22
JPH05504474A (ja) 1993-07-15
ATE148166T1 (de) 1997-02-15
AU6956891A (en) 1991-06-13
CA2072644A1 (en) 1991-05-17

Similar Documents

Publication Publication Date Title
ES2095931T3 (es) Elementos de respuesta al acido retinoico beta, composiciones y pruebas.
Ren et al. Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton
ES2180538T3 (es) Suministro dirigido de vector virico a celulas de mamiferos.
DE69328699D1 (de) Hybridisierungsassay unter Verwendung von verzweigten Nukleinsäuresonden
NL184440C (nl) Proefstrook voor het analyseren van opgeloste stoffen.
ATE255164T1 (de) Säugetier-rezeptoren für das melanocyten- stimulierendes hormon und deren verwendungen
IT8422756V0 (it) Strumento per l'esecuzione di biopsie su tessuti prelevati da organi da esaminare.
Szalmay et al. Bicarbonate and fluid secretion evoked by cholecystokinin, bombesin and acetylcholine in isolated guinea‐pig pancreatic ducts
ATE309980T1 (de) Zubereitungen zur verwendung als therapeutische und nachweismittel
DK1145002T3 (da) Bioluminescenstest for agonister eller antagonister til en calciumkoblet receptor
De Angelis et al. Functional interaction of the subunit 3 of RNA polymerase II (RPB3) with transcription factor‐4 (ATF4)
NL189153C (nl) Preparaat voor het bepalen van het soortelijk gewicht van een waterig proefmonster.
IT1270612B (it) Derivati eterociclo-condensatori di morfinoidi
ATE273390T1 (de) Säugertier edg-7 rezeptor homologen
ES2126597T5 (es) Sistema de sondas que permite efectuar la tipificacion hla dr, y procedimiento de tipificacion que utiliza dichas sondas.
BR9911097A (pt) Método para ensaio fagocìtico
NL7810456A (nl) Werkwijze voor het bereiden van 6,11-dihydro-11-oxodi- benz (b,e)-oxepine-2-azijnzuur en tussenprodukten daarvoor.
FI941611A (fi) Menetelmä aineen vaikutusten arvioimiseksi in vitro
SU827802A1 (ru) Устройство дл испытани анкерной крепи
Sharpe-Timms et al. Models for the study of uterine receptivity for blastocyst implantation
EP0863214A3 (en) Reporter gene construct for measuring G protein coupled receptor activation
NL187995C (nl) Testmiddel en werkwijze voor het bepalen van ureum.
ATE124417T1 (de) 2,19-methylenoxy- und 2,19-methylenthiogebrückte steroide und ihre verwendung als inhibitoren von aromatase und 19-hydroxylase.
Logeat et al. The Two Phosphorylation Reactions of the Progesterone Receptor
FI880709A (fi) Provtestningsfoerfarande och resp. potentiostat.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 502979

Country of ref document: ES